Navigation Links
Drug Delivery Technology Market worth $224.2 Billion By 2017

DALLAS, April 22, 2013 /PRNewswire/ --

The "Drug Delivery Technology Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Global Forecasts To 2017", analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World.


• 118 market data tables

• 29 figures

• 316 pages and an in-depth Table of Content on "Drug Delivery Technology Market"

Early buyers will receive 10% customization on this report.

This report studies the global drug delivery market, with forecast to 2017.

The Drug Delivery Market is divided into Nine Segments, namely:

1. Oral

2. Pulmonary

3. Transdermal

4. Injectable

5. Ocular

6. Nasal

7. Topical

8. Implantable, and

9. Transmucosal Drug Delivery.

Oral Drug Delivery is the largest segment, while pulmonary drug delivery is the fastest growing segment of the global drug delivery market.

Controlled release, dry powder inhalers, transdermal patches, needle-free injectors, auto and pen injectors, and buccal transmucosal tablets are some of the commonly adopted drug delivery technologies. The use of implantable devices for the drug delivery is also on a rise.

The global drug delivery market was worth $142.5 billion in the year 2012. The market will grow at a healthy pace in the next five years due to the rising incidence of chronic diseases such as cardiovascular diseases, diabetes and cancer, growing focus on pediatric and geriatric patients, growing demand for self administration and home healthcare devices, and patent expiries of certain blockbuster drugs.

Strategic collaborations, home care drug delivery devices, and expanding applications of drug delivery into niche therapeutic areas represent vast opportunities for major shareholders of this market. With the growing number of elderly persons, the demand for home care drug delivery devices is also on the rise.

Striking right partnership deal and enhancing the bioavailability of drugs are key burning issues in this market. In spite of a large number of strategic collaborations taking place every year, pharmaceutical and biotechnology companies are facing problems in finding a the right drug delivery partner. Considering this need, a number of national and international conferences are organized by various associations and organizations to facilitate drug delivery partnerships.

North America is the largest market for drug delivery, followed by Europe and Asia. North America and Europe has a well-established pharmaceutical industry, which has stimulated the growth of the drug delivery technology market in these regions. The Asian market is expected to witness a double digit growth over the next five years, owing to the flourishing pharmaceutical industry, development of healthcare infrastructure, and rising disposable income.

Key players in the drug delivery technologies market are 3M Company (U.S.), Alkermes (Ireland), Aptalis Pharma, Inc. (U.S.), Baxter International, Inc. (U.S.), Becton Dickinson & Co. (U.S.), Catalent Pharma Solutions (U.S.), The Dow Chemical Company (U.S.), Endo Pharmaceuticals (U.S.), Johnson & Johnson (U.S.), Nektar Therapeutics (U.S.), SkyePharma PLC (U.K.), and Ypsomed Holding AG (Switzerland).

Buy a copy of this report @

Browse related reports to Biotechnology Market @

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-6006-441

Visit MarketsandMarkets Blog @

Connect with us on LinkedIn @

SOURCE MarketsandMarkets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Pine Grove Nursing Center Uses AccuNurse Interactive Care to Improve Care and Service Delivery
2. ResearchMoz: Nanotech Enabled Drug Delivery Therapeutics Market Will be $136 Billion by the Year 2021: Nanotechnology in Drug Delivery: Global Markets
3. Unigene Receives 2012 Drug Delivery Partnerships Industry Achievement Award
4. BioDelivery Sciences Receives Patent Allowance Triggering $15 Million Milestone Payment from Endo Pharmaceuticals
5. Successful human tests for first wirelessly controlled drug-delivery chip
6. First successful human results achieved: Implantable wireless microchip drug delivery device
7. Floridas Leading Fertility Center Announces Successful Baby Delivery via Egg Freezing
8. New Data Shows GeNO LLC Nitric Oxide Delivery System Provided Nitric Oxide With Low Levels of Nitrogen Dioxide for Heart Transplant Patient Evaluation
9. McLean Report on nanotechnology that may enhance medication delivery and improve MRI performance
10. BioRestorative Therapies Announces Next Generation of Stem Cell Disc Delivery Device
11. Nanotechnology for Drug Delivery: Global Market for Nanocrystals
Post Your Comments:
(Date:11/25/2015)... Mass. , Nov. 25, 2015 Harvard ... biotechnology company developing bioengineered organ implants for life-threatening conditions, ... present at the LD Micro "Main Event" investor conference ... The presentation will be webcast live and posted for ... be available at the conference for one-on-one meetings on ...
(Date:11/25/2015)... 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... a fireside chat discussion at the Piper Jaffray 27th ... . The discussion is scheduled for Wednesday, December 2, ... .  A replay will be available for 14 days ... , Julie NormartVP, Corporate Communications and Business Development , ...
(Date:11/24/2015)... ... ... The United States Golf Association (USGA) today announced Dr. Bruce Clarke, of ... since 1961, the USGA Green Section Award recognizes an individual’s distinguished service to the ... of Iselin, N.J., is an extension specialist of turfgrass pathology in the department of ...
(Date:11/24/2015)... ... November 24, 2015 , ... Copper is an essential ... bound to proteins, copper is also toxic to cells. With a $1.3 million ... (WPI) will conduct a systematic study of copper in the bacteria Pseudomonas aeruginosa ...
Breaking Biology Technology:
(Date:11/18/2015)... , November 18, 2015 ... published a new market report titled  Gesture Recognition Market ... Forecast, 2015 - 2021. According to the report, the global gesture ... is anticipated to reach US$29.1 bn by 2021, at ... North America dominated the global ...
(Date:11/17/2015)... Nov. 17, 2015  Vigilant Solutions announces today that ... Board of Directors. --> ... retiring from the partnership at TPG Capital, one of ... over $140 Billion in revenue.  He founded and led ... the TPG companies, from 1997 to 2013.  In his ...
(Date:11/12/2015)... Nov. 12, 2015  A golden retriever that stayed ... dystrophy (DMD) has provided a new lead for treating ... the Broad Institute of MIT and Harvard and the ... . Cell, pinpoints a protective ... the disease,s effects. The Boston Children,s lab of ...
Breaking Biology News(10 mins):